Penn state university: to award the base period
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN261200900026C
- Awardee
-
Pennsylvania State University UEI TNKGNDAWB445
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,540,387
Award facts
- Opportunity
-
- N02CB8101374 Solicitation number
- Synthesis of Selected Chemical Carcinogens, Derivatives of Polynuclear Aromatic Hydrocarbons and Chemopreventive Agents Award Notice · Posted Aug 17, 2009
- Contract value 59% obligated
-
- $1,544,922.00 Current, with exercised options
- $2,605,929.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- 6810 Chemicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 7 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Hershey, PA 17033, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$4,535 | |
| Exercise an Option | $530,270 | |
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $514,822 | |
| Other Administrative Action | $0 | |
| Original award | $499,830 |
About this award
This is a federal contract award from the National Cancer Institute, a civilian agency, to Pennsylvania State University (Penn State) to perform research and synthesis of selected chemical carcinogens, derivatives of polycyclic aromatic hydrocarbons, and chemopreventive agents. The contract has a ceiling value of $2,605,929.00 and a period of performance from August 1, 2009 to July 31, 2012. The contract is a definitive contract with a cost-no-fee pricing type and does not have a set-aside designation. Penn State, as the prime contractor, has collaborated with subrecipients like Duke University and Wayne State University on this research effort. The contract award is associated with a larger indefinite delivery contract (IDC) that Penn State holds with the National Institute of Allergy and Infectious Diseases, valued at up to $146,300,000 through July 2031, for the development and use of animal and animal replacement models for evaluating therapeutics, vaccines, and diagnostics against infectious diseases.
Quick answers
Who was awarded contract HHSN261200900026C?
HHSN261200900026C was awarded to Pennsylvania State University by National Cancer Institute (National Institutes of Health) on August 1, 2009.
How much is contract HHSN261200900026C worth?
The government has obligated $1,540,387 on HHSN261200900026C. Its current value, with exercised options, is $1,544,922. Its potential value, with all options, is $2,605,929.
Was contract HHSN261200900026C competed?
The extent of competition for HHSN261200900026C was full and open competition. The government received 7 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award